SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Teladoc Health (TDOC " 8 found 🔀 AI-powered Shuffle
Is Teladoc Health (TDOC) Cheap Following Its New AI Tools?
Teladoc Health (TDOC) just rolled out two AI tools inside its Solo platform, SoloVitals and SoloScribe, aimed at contactless vital sign tracking and streamlined clinical note taking for hospital and health system clients. Despite Teladoc Health unveiling AI tools aimed at making virtual visits smoother for hospitals, the 30-day share price return is down 10% and the 90-day move has fallen 41.24%. The 5-year total shareholder return has declined 95.88%, pointing to longer term momentum that...
Teladoc Health (TDOC) Stock Looks Reasonable As Shares Stay Down 96%
Teladoc Health has seen its share price grind lower over the years, even as it pushes new telehealth tools into hospitals and clinics. This raises a straightforward question for you as an investor: Is the current US$5.77 price properly anchored to the cash flows the business can realistically produce? Over the past 5 years the stock has fallen 95.7%, so the market has already repriced a huge amount of optimism and that reset now frames any discussion of what its future cash flows are...
Teladoc Health (TDOC), Why Is It Back In The Spotlight?
Teladoc Health (TDOC) just announced a change in its legal leadership. Longtime Chief Legal Officer Adam Vandervoort plans to step down in early November, and current senior legal executive Jonathan Dorfman is set to take over. At around US$6.09 per share, Teladoc Health has seen its 90 day share price return fall about 28%, and the 1 year total shareholder return decline roughly 26%. This suggests momentum has been fading even as management refreshes its legal leadership and continues to...
Teladoc Health (TDOC) Missed On Earnings And Guided Lower, Is The Discount Too Wide?
Why Teladoc Health’s latest earnings matter for investors Teladoc Health (TDOC) set the tone for the stock this week after reporting quarterly results that showed a 4% revenue decline, missed forecasts on profitability, and softer guidance for the coming quarter. The update pointed to a 9.2% average drop in customer spending in recent years even as user counts grew. Management signaled expectations for another period of lower revenue and negative earnings per share. Recent trading suggests...
Teladoc Health (TDOC) Could Be 58% Undervalued As A New CFO Takes Over
Why Teladoc Health Brought In A New CFO Teladoc Health (TDOC) has appointed Michael Grasher as Chief Financial Officer, effective 31 August 2026, giving investors a fresh focal point for assessing the company’s financial leadership and capital allocation plans. The Teladoc Health share price has eased in the past day and is down about 11% over the past month, while the 1 year total shareholder return has fallen roughly 19% and the 5 year total shareholder return has declined about 95%, so...
Teladoc Health (TDOC) Stock Valuation As Analyst Sentiment Improves Despite Expected Earnings Decline
Analyst sentiment shift and near term expectations Teladoc Health (TDOC) is back on investors’ radar after analysts turned more positive in their earnings estimates, even as they still expect a 26.32% year over year decline in the upcoming report. This change in sentiment, paired with a recent 1.44% gain that outperformed key indices, has focused attention on how the company’s virtual care and mental health businesses might shape near term performance. See our latest analysis for Teladoc...
A Look At Teladoc Health’s (TDOC) Valuation After Analyst Upgrades And Earnings Surprise
Why Teladoc Health is back on investors’ radar Teladoc Health (TDOC) is attracting fresh attention after a run of analyst upgrades tied to its BetterHelp mental health segment, stronger than expected quarterly results, and new plans around artificial intelligence and international expansion. See our latest analysis for Teladoc Health. Despite the recent enthusiasm around upgrades and earnings, Teladoc Health’s 7 day share price return of 6.63% and 30 day gain of 9.84% sit against a much...
Is Teladoc Health (TDOC) A Potential Opportunity After Prolonged Share Price Weakness
If you are wondering whether Teladoc Health at around US$5.91 is a bargain or a value trap, this breakdown is designed to give you a clear, structured view of where the stock stands today. The share price has retreated recently, with a 2.6% decline over the last 7 days, a 17.0% decline over 30 days, a 16.2% decline year to date, and a 43.8% decline over the past year, on top of a much larger 79.9% decline over 3 years and 97.8% over 5 years. Recent coverage around Teladoc Health has focused...